Paul O. Verhoeven
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 25
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 13
- Microbiology top 5%
- Molecular Medicine top 10%
-
- Streptococcal Infections and Treatments 14
-
- Infection Control and Ventilation 11
-
- Infective Endocarditis Diagnosis and Management 9
- Respiratory viral infections research 6
-
- Bacterial biofilms and quorum sensing 8
-
- COVID-19 and healthcare impacts 6
- Co-authors
- Bruno PozzettoFlorence GrattardP. BerthelotAnne CarricajoÉlisabeth Botelho-NeversF. LuchtSylvie PilletJulie Gagnaire
- Partner nations
- FranceSwitzerlandAustralia
In The Last Decade
Paul O. Verhoeven
69 papers receiving 970 citations
Peers
Comparison fields: 5 of 115
- Infectious Diseases 442
- Clinical Biochemistry 145
- Microbiology 128
- Applied Microbiology and Biotechnology 27
- Molecular Medicine 59
Countries citing papers authored by Paul O. Verhoeven
This map shows the geographic impact of Paul O. Verhoeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul O. Verhoeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul O. Verhoeven more than expected).
Fields of papers citing papers by Paul O. Verhoeven
This network shows the impact of papers produced by Paul O. Verhoeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul O. Verhoeven. The network helps show where Paul O. Verhoeven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul O. Verhoeven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 15 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 24 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 4 | |
| 13 | 2018 | 5 | |
| 14 | 2016 | 33 | |
| 15 | 2015 | 7 | |
| 16 | 2015 | 1 | |
| 17 | 2014 | 16 | |
| 18 | 2014 | 8 | |
| 19 | 2013 | 1 | |
| 20 | 2012 | 20 |
About Paul O. Verhoeven
Paul O. Verhoeven is a scholar working on Infectious Diseases, Clinical Biochemistry and Microbiology, having authored 75 papers that have together received 989 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (25 papers), Streptococcal Infections and Treatments (14 papers), Bacterial Identification and Susceptibility Testing (13 papers), Infection Control and Ventilation (11 papers), Infective Endocarditis Diagnosis and Management (9 papers), Bacterial biofilms and quorum sensing (8 papers), COVID-19 and healthcare impacts (6 papers) and Respiratory viral infections research (6 papers). The work is most often cited by research in Infectious Diseases (442 citations), Clinical Biochemistry (145 citations) and Microbiology (128 citations). Paul O. Verhoeven has collaborated with scholars based in France, Switzerland and Australia. Frequent co-authors include Bruno Pozzetto, Florence Grattard, P. Berthelot, Anne Carricajo, Élisabeth Botelho-Nevers, F. Lucht, Sylvie Pillet, Julie Gagnaire, Annick Mercenier and Philippe Andrès.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.